Perez MI. The stepwise approach to the treatment of melasma. Cutis. 2005;75:217-222. PMID: 15916218
Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455-458. PMID: 10560271
Prignano F, Ortonne JP, Buggiani G, et al. Therapeutical approaches in melasma. Dermatol Clin. 2007;25:337-342. PMID: 17662899
Salem A, Gamil H, Ramadan A, et al. Melasma: treatment evaluation. J Cosmet Laser ther. 2009;11:146-150. doi: 10.1080/14764170902842549. PMID: 19340686
Rose P. Pigmentary disorders. Med Clin North Am. 2009;93:1225-1239. doi: 10.1016/j.mcna.2009.08.005. PMID: 19932328
Rendon M, Berneburg M, Arellano I, et al. Treatment of melasma. J Am Acad Dermatol. 2006;54(5 suppl 2):S 272-S281. PMID: 16631968
James WD, Berger TG, Elston DM. Andrews’ diseases of the skin clinical dermatology. 10th ed. Toronto: Saunder, Elsevier; 2006
Lawley TJ, Yancey KB. Alterations in the skin. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 15th ed. New York: McGraw-Hill; 2001:305-309
Habif TP. Light-related diseases and disorders of pigmentation. In: Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. St. Louis, MO: Elsevier; 2016:779-782.
Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Therapy Lett. 2016 Jan;21(1):1-7. PMID: 27224897
Mahajan VK, Patil A, Blicharz L, et al. Medical therapies for melasma. J Cosmet Dermatol. 2022 Sep;21(9):3707-3728. doi: 10.1111/jocd.15242. Accessed 08 Nov 2023. PMID: 35854432
Cassiano DP, Espósito ACC, da Silva CN, et al. Update on melasma-part II: Treatment. Dermatol Ther (Heidelb). 2023 Sep;12(9):1989-2012. doi: 10.1007/s13555-022-00780-4. Accessed 08 Nov 2023. PMID: 35906506
Goel A, Trivedi N. Current updates on melasma treatments. Cosmoderma. 2023 May;3(79). doi: 10.25259/CSDM_84_2023.
Kang S, Amagai M, Bruckner AL, et al, eds. Fitzpatrick's Dermatology. 9th ed: McGraw-Hill Education; 2019.
Han HJ, Kim JC, Park YJ, et al. Targeting the dermis for melasma maintenance treatment. Sci Rep. 2024 Jan;14(1):949. doi: 10.1038/s41598-023-51133-w. PMID: 38200171
Jiryis B, Toledano O, Avitan-Hersh E, et al. Management of melasma: Laser and other therapies-review study. J Clin Med. 2024 Mar;13(5):1468. doi: 10.3390/jcm13051468. PMID: 38592701
Liu Y, Wu S, Wu H, et al. Comparison of the efficacy of melasma treatments: A network meta-analysis of randomized controlled trials. Front Med (Lausanne). 2021 Sep;8:713554. doi: 10.3389/fmed.2021.713554. PMID: 34660626
Zhou LL, Baibergenova A. Melasma: systematic review of the systemic treatments. Int J Dermatol. 2017 Sep;56(9):902-908. doi: 10.1111/ijd.13578. PMID: 28239840
National Institute of Child Health and Human Development. Azelaic acid. [Updated 2024 Feb 15]. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006. https://ncbi.nlm.nih.gov/books/NBK501422/.
Ghasemiyeh P, Fazlinejad R, Kiafar MR, et al. Different therapeutic approaches in melasma: advances and limitations. Front Pharmacol. 2024 Apr;15:1337282. doi: 10.3389/fphar.2024.1337282. PMID: 38628650
